Control of Vertebrate Development by MYC

Por Hurlin, Peter J.
Publicado em 2013

Differential Regulation of N-Myc and c-Myc Synthesis, Degradation, and Transcriptional Activity by the Ras/Mitogen-activated Protein Kinase Pathway

Por Kapeli, Katannya, Hurlin, Peter J.
Publicado em 2011

MNT and Emerging Concepts of MNT-MYC Antagonism

Por Yang, Guang, Hurlin, Peter J.
Publicado no Genes (Basel) (2017)

MYC needs MNT

Por Link, Jason M., Hurlin, Peter J.
Publicado em 2013

Suppression of FGFR3- and MYC-dependent oncogenesis by tubacin: association with HDAC6-dependent and independent activities

Por Ota, Sara, Zhou, Zi-Qiang, Hurlin, Peter J.
Publicado no Oncotarget (2017)

Development of human gene reporter cell lines using rAAV mediated homologous recombination

Por Fernandez, Sandra L., Russell, David W., Hurlin, Peter J.
Publicado em 2007

The role of senescence and prosurvival signaling in controlling the oncogenic activity of FGFR2 mutants associated with cancer and birth defects

Por Ota, Sara, Zhou, Zi-Qiang, Link, Jason M., Hurlin, Peter J.
Publicado em 2009

Inflammatory Disease and Lymphomagenesis Caused by Deletion of the Myc Antagonist Mnt in T Cells

Por Dezfouli, Shala, Bakke, Antony, Huang, Jie, Wynshaw-Boris, Anthony, Hurlin, Peter J.
Publicado em 2006

OX40 engagement stabilizes Mxd4 and Mnt protein levels in antigen-stimulated T cells leading to an increase in survival

Por Vasilevsky, Nicole A., Ruby, Carl E., Hurlin, Peter J., Weinberg, Andrew D.
Publicado em 2011

Mutant activated FGFR3 impairs endochondral bone growth by preventing SOX9 downregulation in differentiating chondrocytes

Por Zhou, Zi-Qiang, Ota, Sara, Deng, Chuxia, Akiyama, Haruhiko, Hurlin, Peter J.
Publicado no Hum Mol Genet (2015)

Mnt–Max to Myc–Max complex switching regulates cell cycle entry

Por Walker, William, Zhou, Zi-Qiang, Ota, Sara, Wynshaw-Boris, Anthony, Hurlin, Peter J.
Publicado em 2005

Mnt modulates Myc-driven lymphomagenesis

Por Campbell, Kirsteen J, Vandenberg, Cassandra J, Anstee, Natasha S, Hurlin, Peter J, Cory, Suzanne
Publicado no Cell Death Differ (2017)

Sequential and Coordinated Actions of c-Myc and N-Myc Control Appendicular Skeletal Development

Por Zhou, Zi-Qiang, Shung, Chia-Yi, Ota, Sara, Akiyama, Haruhiko, Keene, Douglas R., Hurlin, Peter J.
Publicado em 2011

A critical role for Mnt in Myc-driven T-cell proliferation and oncogenesis

Por Link, Jason M., Ota, Sara, Zhou, Zi-Qiang, Daniel, Colin J., Sears, Rosalie C., Hurlin, Peter J.
Publicado em 2012

Deletion of Mnt leads to disrupted cell cycle control and tumorigenesis

Por Hurlin, Peter J., Zhou, Zi-Qiang, Toyo-oka, Kazuhito, Ota, Sara, Walker, William L., Hirotsune, Shinji, Wynshaw-Boris, Anthony
Publicado em 2003

A repressor protein, Mnt, is a novel negative regulator of vascular smooth muscle cell hypertrophy by angiotensin II and neointimal hyperplasia by arterial injury

Por Takayanagi, Takehiko, Eguchi, Akito, Takaguri, Akira, Hinoki, Akinari, Bourne, Allison M., Elliott, Katherine J, Hurlin, Peter J., Eguchi, Satoru
Publicado em 2013

Pan-Cancer Alterations of the MYC oncogene and its Proximal Network across The Cancer Genome Atlas

Por Schaub, Franz X., Dhankani, Varsha, Berger, Ashton C., Trivedi, Mihir, Richardson, Anne B., Shaw, Reid, Zhao, Wei, Zhang, Xiaoyang, Ventura, Andrea, Liu, Yuexin, Ayer, Donald E., Hurlin, Peter J., Cherniack, Andrew D., Eisenman, Robert N., Bernard, Brady, Grandori, Carla
Publicado no Cell Syst (2018)